Bliss Kelly 4

What Happened

• Bliss Kelly, President, U.S. Group Health at Teladoc Health, sold 2,500 shares on June 29, 2026 at $8.50 per share, generating gross proceeds of $21,250. The Form 4 was filed on June 30, 2026. The transaction is reported as a sale (code S).

Key Details

• Transaction date: 2026-06-29; Filing date / Period of Report: 2026-06-30 / 2026-06-29
• Price per share: $8.50; Shares sold: 2,500; Proceeds: $21,250
• Transaction type: Open market or private sale (reported as S)
• Footnote: Sale was effected pursuant to a Rule 10b5-1 trading plan adopted August 14, 2025
• Shares owned after transaction: Not disclosed in the provided filing
• Timeliness: Filed the day after the trade; no late filing indicated

Context

• Trades under a Rule 10b5-1 plan are typically pre-scheduled, which can make sales routine rather than a signal about company prospects. Sales are common for liquidity or diversification and, by themselves, do not necessarily indicate insider sentiment.